Lactate dehydrogenase and other biomarkers appear to predict risk of critical illness and death, and testing soon after exposure is associated with high rates of false negatives, new studies showed.
Recent papers addressed how to treat strokes and addiction during a pandemic, and ACP issued statements supporting physicians who bring their own personal protective equipment or speak out about unsafe conditions.
The Infectious Diseases Society of America releases guidance on infection prevention, hospitalists look at how to maintain their own health and physical distancing during the pandemic, and experts highlight ethical problems with policies on
Two studies report outcomes of patients hospitalized in the U.S., the CDC focuses on incidence among the homeless, and the FDA warns about antibody testing.
The American Thoracic Society addresses potential use of hydroxychloroquine for patients with COVID-19 and pneumonia, and two case series reports describe use of convalescent plasma in critically ill patients with COVID-19 in China.
Studies offered further support for anticoagulation in patients with COVID-19 but showed no benefit from hydroxychloroquine or lopinavir-ritonavir. The authors of recent pneumonia guidelines explained how the recommendations apply to COVID-19
ACP provided resources on telehealth and physician well-being, while cardiology groups advised patients to stay on angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers.
excluded. In situations of potential outbreaks or novel, virulent pathogens (e.g., Ebola, Middle East respiratory syndrome coronavirus), enforcing isolation precautions should be prioritized, and hospitals should consider restricting nonessential
Trials offered inconclusive evidence about remdesivir, a pilot study found benefits to prone self-positioning for ED patients, and other research quantified the risk of QT prolongation with hydroxychloroquine and azithromycin and provided
It's time to cram on managing mechanical ventilation.